Study of blood thinners in people with high lipoprotein(a)
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at how blood platelets work in people who have high levels of lipoprotein(a), a type of fat in the blood that can increase heart risk. It tests if common blood thinners (aspirin and clopidogrel) work differently in these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a blood test showing high lipoprotein(a) (≥ 125 nmol/L) or low levels (< 25–30 nmol/L) for comparison.
- You have not had a heart attack, stroke, or other sudden heart problem in the last 3 months.
- You are not currently pregnant, breastfeeding, or planning to become pregnant.
- You are not taking certain blood thinners (like Warfarin, Plavix, or Xarelto) that can't be paused safely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a type of fat in the blood called lipoprotein(a) and your body's ability to break down clots affect heart disease or heart valve disease. It is for people who are already taking certain cholesterol-lowering medicines or have severe aortic valve narrowing from calcium buildup.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This study looks at how anti-platelet medicines like aspirin and clopidogrel work in people with hardened arteries (atherosclerosis) or peripheral artery disease (PAD). The goal is to understand how these drugs affect your body's clotting system.
This study looks at how blood fats (lipids) interact with platelets to help understand blood clot risk and possible future treatments. It is for people over 40 without known heart or artery disease.
This trial tests whether a new once-daily pill called SAL0137 can safely lower Lp(a), a type of cholesterol that raises heart attack and stroke risk. It's for adults with high Lp(a) and other heart risk factors, like prior heart problems or diabetes.
This study looks at how fats (lipids) in your blood affect blood cells called platelets, which help with clotting. It includes both healthy people and those with high cholesterol or other fat issues.
Hear when a new Cardiovascular Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.